跳至主要内容
临床试验/JPRN-UMIN000014836
JPRN-UMIN000014836已完成未知

A pilot study to evaluate efficacy and safety of resveratrol for muscular dystrophy. - A pilot study of resveratrol for muscular dystrophy.

Sapporo Medical University0 个研究点目标入组 10 人开始时间: 2014年8月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Hypersensitivity to resveratrol. 2) Disqualified for trial by principal investigator.

研究者

相似试验

进行中(未招募)
不适用
A pilot study to examine the efficacy and safety of escitalopram in doses up to 50 mg for the treatment of patients with Major Depressive Disorder (MDD). - Resistant Depression StudyMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSMajor Depressive Disorder
EUCTR2008-003359-58-GBCPS Research60
已完成
2 期
A pilot study to explore the efficacy and safety of jam oral immunotherapy with hypoallergenized cow's milk for children with cow's milk allergyfood allergy (cow&#39s milk)
JPRN-UMIN000018372ational Center for Child Health and Development10
已完成
不适用
Combination therapy of Visudyne, Minocycline, Dexamethasone and Ranibizumab (VIMDER) for the treatment of subfoveal choroidal neovascularisation (CNV)Age-related macular degeneration
ISRCTN34410935King's College Hospital NHS Foundation Trust (UK)20
已完成
不适用
A pilot study to examine the safety and efficacy of posterior juxta-scleral (80 mg) triamcinolone acetonide, administration, in addition to Visudyne (verteporfin) photodynamic therapy for predominantly classic choroidal neovascularisation secondary to age-related macular degeneration: an open-label, randomised, active controlled trial
ISRCTN33957677King's College Hospital (UK)80
已完成
不适用
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucoma
ISRCTN23263504Transcend Medical, Inc.™ (USA)20